by Clinical Neuropsychologist | Wednesday, June 25, 2025 | Neuroimaging
ABSTRACT Background and Purpose Diffusion tensor imaging (DTI) is commonly used to assess the integrity of gray and white matter (WM) structures in progressive supranuclear palsy (PSP). Beyond DTI, nontraditional diffusion techniques such as diffusion kurtosis imaging...
by Clinical Neuropsychologist | Thursday, June 19, 2025 | Neuroimaging
ABSTRACT Background and Purposes The Alberta Stroke Program Early CT Score-based net water uptake (ASPECTS-NWU) is a quantitative imaging biomarker used to assess early ischemic changes in acute ischemic stroke patients. ASPECTS-NWU has been investigated in...
by Clinical Neuropsychologist | Tuesday, June 17, 2025 | Neuroimaging
ABSTRACT Progressive supranuclear palsy (PSP) is a complex neurodegenerative disorder that is frequently misdiagnosed, largely due to its overlapping clinical features with other neurodegenerative diseases, such as Parkinson’s disease and multiple system...
by Clinical Neuropsychologist | Saturday, June 14, 2025 | Neuroimaging
ABSTRACT Background and Purpose The oculomotor nerve (OCN) innervates the eye muscles and can be affected by inflammatory, compressive, and pathological conditions. Diffusion MRI (dMRI) tractography shows the potential ability to describe the trajectory of the OCN....
by Clinical Neuropsychologist | Sunday, June 8, 2025 | Neuroimaging
ABSTRACT Background and Purpose M2 middle cerebral arterial (MCA) occlusions present a greater radiological challenge when compared to more proximal occlusions and additional signs aiding detection could be helpful. We routinely image patients with a dual-phase CT...
